Delcor Asset - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsDelcor Asset

Delcor Asset

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Kenacort	Triamcinolone	1982-01-01	2027-2034	Adrenal insufficiency , Allergic rhinitis perennial , Ankylosing spondylitis , Atopic dermatitis , Berylliosis , Bronchial spasm , Dermatitis herpetiformis , Erythema multiforme , Facial dermatoses , Foot dermatoses , Hand dermatoses , Hemolytic anemia , Hypercalcemia , Inflammation , Leg dermatoses , Multiple sclerosis , Nephrotic syndrome , Pemphigus , Pulmonary tuberculosis , Rheumatic diseases , Scalp dermatoses , Serum sickness , Synovitis , Systemic lupus erythematosus , Thyroiditis , Ulcerative colitis , Uveitis
Kenalog	Triamcinolone	1982-01-01	2027-2034	Adrenal insufficiency , Allergic rhinitis perennial , Ankylosing spondylitis , Atopic dermatitis , Berylliosis , Bronchial spasm , Dermatitis herpetiformis , Erythema multiforme , Facial dermatoses , Foot dermatoses , Hand dermatoses , Hemolytic anemia , Hypercalcemia , Inflammation , Leg dermatoses , Multiple sclerosis , Nephrotic syndrome , Pemphigus , Pulmonary tuberculosis , Rheumatic diseases , Scalp dermatoses , Serum sickness , Synovitis , Systemic lupus erythematosus , Thyroiditis , Ulcerative colitis , Uveitis
Mycolog-ii	Nystatin, Triamcinolone	1985-05-01		Chronic mucocutaneous candidiasis , Cutaneous candidiasis , Mycoses , Oral candidiasis , Vulvovaginal candidiasis
Mycostatin	Nystatin	1982-01-01		Chronic mucocutaneous candidiasis, Cutaneous candidiasis, Mycoses, Oral candidiasis, Vulvovaginal candidiasis

1

2

>

Clinical Trials

No data

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use